Belgium· BE-AMP-SAM471626-00

Keppra 1000 mg

A levetiracetam product containing levetiracetam, registered in Belgium by PI Pharma. The same ATC class is registered in 19 of our 19 countries.

ATC N03AX14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKeppra 1000 mgATCN03AX14REGISTER NO.BE-AMP-SAM471626-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Levetiracetam is registered in 19 of 19 countries.

Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 11 of them publish a price we can compare per daily dose

Levetiracetam · ATC N03AX14

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levetiracetam costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $2.54 in Switzerland — a ×2.1 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levetiracetam · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.54
  • IT Italy$2.14
  • FR France$1.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Levetiracetam
Manufacturer
PI Pharma
Country
Belgium (BE)
ATC code
N03AX14
ATC class
Levetiracetam
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    3144664
  • be_apb
    7713100

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for levetiracetam.

Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levetiracetam · interactions on record

258 records

  • 50 moderate
  • 3 minor
  • 164 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levetiracetam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levetiracetam products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Levebon, Levetiracetam +pharma
  • Bulgaria · Levebon, Леветиракон Pharmacons
  • Cyprus · Levetiracetam Noridem, Lyberen
  • Czechia · Dretacen, Epiletam
  • Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
  • Denmark · Kevesy, Levetiracetam ”1a Farma”
  • Estonia · Levetiracetam Zentiva, Normeg
  • Spain · Laurak, Levetiracetam Almus
  • Finland · Larofec, Levetiracetam 1a Farma
  • France · Levetiracetam Accord, Levetiracetam Aguettant
  • United Kingdom (Northern Ireland) · Desitrend, Genlev
  • Greece · Ession, Kepricet
  • Croatia · Levetiracetam Kalceks, Lyvam
  • Hungary · Epiletam, Levetiracetam Kabi
  • Ireland · Larofec, Levetiracetam Brillpharma
  • Iceland · Keppra, Levetiracetam Accord
  • Italy · Epitiram, Grifoxina
  • Liechtenstein · Keppra, Levetiracetam Accord
  • Lithuania · Dretacen, Levetiracetam Kalceks
  • Luxembourg · Larofec, Levetiracetam Micro Labs
  • Latvia · Levetiracetam Kalceks
  • Malta · Levetiracetam Accord, Levetiracetam Aurobindo
  • Netherlands · Dretacen, Larofec
  • Norway · Keppra, Larofec
  • Poland · Cezarius, Lepsitam
  • Portugal · Cinaz, Laurak
  • Romania · Levetiracetam Accord, Levetiracetam Arena
  • Sweden · Levebon, Levetiracetam
  • Slovenia · Levetiracetam Kalceks
  • Slovakia · Epiletam, Levetiracetam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9128f9a-3f2d-4a41-8bfa-a0fea3b58222
GET /v1/drugs/e9128f9a-3f2d-4a41-8bfa-a0fea3b58222?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Keppra 1000 mg",
  "name_fr": "Keppra 1000 mg",
  "name_nl": "Keppra 1000 mg",
  "amp_code": "SAM471626-00",
  "strengths": [
    "1000.0000",
    "1000.0000",
    "1000.0000"
  ],
  "pack_count": 14,
  "substances": [
    "Levetiracetam"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Levetiracetam",
  "authorisation_numbers": [
    "1637PI0339F003",
    "1637PI0445F003"
  ]
}

See everything about levetiracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.